The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriad Regulatory News (TRD)

Share Price Information for Triad (TRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 246.00
Bid: 260.00
Ask: 270.00
Change: -14.00 (-5.38%)
Spread: 10.00 (3.846%)
Open: 260.00
High: 265.00
Low: 246.00
Prev. Close: 260.00
TRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

11 Jul 2022 17:00

RNS Number : 0654S
Triad Group Plc
11 July 2022
 

Triad Group Plc

("Triad" or "the Company")

Director Dealings

The Company announces that it has been informed that, on 7 July 2022, Tim Eckes (Client Services Director) has in order to effect a "Bed and ISA" transaction, sold 15,686 ordinary shares of £0.01 each ("Ordinary Shares") at a price of 120.00 pence per Ordinary Share and then repurchased into his Individual Savings Account (ISA), the same number of 15,686 Ordinary Shares at an average price of 120.35 pence per Ordinary Share.

Following the completion of these transactions his ultimate beneficial ownership is unchanged and remains at 120,374 Ordinary Shares in total, representing approximately 0.73% of the Company's total voting rights.

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the transactions.

1.

Details of PDMR / person closely associated with them

a)

Name

Tim Eckes

2.

Reason for the notification

a)

Position / status

Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Triad Group Plc

b)

LEI

213800MDNBFVEQEN1G84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary shares of £0.01 each

 

 

ISIN: GB0009035741

b)

Nature of the transaction

On market sale of Ordinary Shares and immediate repurchase by way of Bed and ISA arrangement

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£1.2000 (sale)

£1.2025 (purchase)

£1.3350 (purchase)

£1.3350 (purchase)

15,686

15,573

84

29

d)

Aggregated information

-Aggregated sale

-Aggregated purchase

 

15,686 - average price of £1.2000

15,686 - average price of £1.2035

e)

Date of the transaction

7 July 2022

f)

Place of the transaction

LONDON STOCK EXCHANGE XLON

 

For further information, please contact:

Triad Group Plc

James McDonald

Finance Director and Company Secretary

01908 278 450

 

Arden Partners Plc

Ruari McGirr

Alexandra Campbell-Harris

Tel: 020 7614 5900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUAUSRUUUBAAR
Date   Source Headline
14th Mar 20243:00 pmRNSBlock listing Interim Review
7th Mar 202411:00 amRNSTrading Statement
29th Feb 20242:00 pmRNSTotal Voting Rights
3rd Jan 202411:43 amRNSTotal Voting Rights
21st Dec 20231:00 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSHalf-year Report
14th Sep 202312:00 pmRNSBlock listing Six Monthly Return
27th Jul 20231:30 pmRNSResult of AGM
25th Jul 20233:00 pmRNSTotal Voting Rights
4th Jul 20236:00 pmRNSCorrection - Dividend Declaration
4th Jul 20233:00 pmRNSDividend Declaration
4th Jul 20233:00 pmRNSNotice of AGM
3rd Jul 202312:00 pmRNSDirector/PDMR Shareholding
30th Jun 20231:00 pmRNSDirector/PDMR Shareholding
28th Jun 20231:30 pmRNSDirectorate Change
28th Jun 20231:30 pmRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector dealings
12th Jun 20237:00 amRNSAnnual Financial Report
1st Jun 20237:00 amRNSDirectorate Change
9th May 20234:30 pmRNSDirector/PDMR Shareholding
31st Mar 202310:30 amRNSChange of Broker
14th Mar 20233:00 pmRNSBlock listing Review
28th Feb 202311:00 amRNSHolding(s) in Company
15th Feb 202312:00 pmRNSHolding(s) in Company
18th Jan 20234:40 pmRNSSecond Price Monitoring Extn
18th Jan 20234:35 pmRNSPrice Monitoring Extension
18th Jan 20237:00 amRNSTrading Statement
22nd Dec 20229:00 amRNSTotal Voting Rights
1st Dec 20227:00 amRNSHalf-year Report
10th Nov 202212:00 pmRNSTotal Voting Rights
14th Sep 202212:00 pmRNSBlock Listing Six Monthly Review
12th Sep 202212:00 pmRNSHolding(s) in Company
8th Sep 20224:30 pmRNSDirector/PDMR Shareholding
21st Jul 202210:00 amRNSResult of AGM
15th Jul 20229:00 amRNSTotal Voting Rights
11th Jul 20225:00 pmRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSNotice of AGM
28th Jun 20227:00 amRNSDividend Declaration
9th Jun 20225:00 pmRNSTotal Voting Rights
7th Jun 202212:30 pmRNSHolding(s) in Company
1st Jun 20223:00 pmRNSHolding(s) in Company
31st May 20224:30 pmRNSDirector/PDMR Shareholding
30th May 20223:00 pmRNSDirector/PDMR Shareholding
30th May 20223:00 pmRNSDirector/PDMR Shareholding
30th May 20223:00 pmRNSHolding(s) in Company
26th May 20227:00 amRNSAnnual Financial Report
12th Apr 20224:30 pmRNSHolding(s) in Company
31st Mar 20224:30 pmRNSGrant of Restrictive Share Units
25th Mar 20224:45 pmRNSResult of Meeting
14th Mar 20224:00 pmRNSBlock listing six monthly return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.